Evaluation of Acebilustat, a Selective Inhibitor of Leukotriene B4 Biosynthesis, for Treatment of Outpatients With Mild-Moderate Coronavirus Disease 2019: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. - Levitt JE; Hedlin H; Duong S; Lu D; Lee J; Bunning B; Elkarra N; Pinsky BA; Heffernan E; Springman E; Moss RB; Bonilla HF; et al. (Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023)